Chartwell Investment Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-39,600
Closed -$608K 446
2023
Q3
$608K Hold
39,600
0.02% 384
2023
Q2
$942K Buy
39,600
+6,001
+18% +$143K 0.03% 357
2023
Q1
$855K Sell
33,599
-27,453
-45% -$699K 0.03% 356
2022
Q4
$1.78M Buy
61,052
+3,488
+6% +$102K 0.07% 275
2022
Q3
$1.18M Buy
+57,564
New +$1.18M 0.05% 329